Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation
Atsushi Nakajima(Yokohama City University), Michael Camilleri(CSIRO Manufacturing), Shinsuke Kurosu(EA Pharma (Japan)), Kazuki Matsuda(The University of Tokyo), Shinya Taniguchi(Konan University), Jan P. Mattsson(Novartis (Switzerland)), Per‐Göran Gillberg(Uppsala University), Tomoko Hasunuma(Kitasato Institute Hospital), Sonoko Ishizaki(EA Pharma (Japan))
Cited by 26
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Intestinal barrier function in health and gastrointestinal disease
|Neurogastroenterology & Motility|2012|886
Laboratory characterisation of coal reservoir permeability for primary and enhanced coalbed methane recovery
|International Journal of Coal Geology|2009|477